Table 2.
Top 10 drug predictions for the EGFR–TKI resistance–specific key gene TIMP1.
| Drug | Interaction type and directionality | Sources | Query score | Interaction score |
|---|---|---|---|---|
| Liarozole | n/a | NCI | 2.92 | 4.25 |
| Rovelizumab | Antagonist (inhibitory) | ChemblInteractions | 1.46 | 2.13 |
| Dimethyl sulfoxide | n/a | NCI | 1.46 | 2.13 |
| Clarithromycin | n/a | NCI | 1.35 | 0.98 |
| Fentanyl | n/a | NCI | 0.67 | 0.49 |
| Phenylephrine | n/a | NCI | 0.63 | 0.91 |
| Theophylline | n/a | NCI | 0.37 | 0.53 |
| Morphine | n/a | NCI | 0.28 | 0.41 |
| Hydrocortisone | n/a | NCI | 0.23 | 0.34 |
| Atorvastatin | n/a | NCI | 0.15 | 0.21 |